Rare Disease Genetic Testing Market

Rare Disease Genetic Testing Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032
Frequently asked questions about this report

Based on disease type, the Rare Disease Genetic Testing market is segmented into neurological disorders, immunological disorders, hematology diseases, endocrine and metabolism diseases, cancer, musculoskeletal disorders, and others.

Major players operating in the global Rare Disease Genetic Testing market include Quest Diagnostics Inc., Centogene N.V., Invitae Corporation, 3billion, Inc., Arup Laboratories, Eurofins Scientific, Strand Life Sciences, Ambry Genetics, Perkin Elmer, Inc., Macrogen, Inc., Baylor Genetics, Color Genomics, Inc., Health Network Laboratories, Preventiongenetics, Progenity, Inc., Coopersurgical, Inc., Fulgent Genetics Inc., Myriad Genetics, Inc., Laboratory Corporation of America Holdings, Opko Health, Inc. and others.

The Rare Disease Genetic Testing analysis market has been assessed for the years 2022 to 2032.